Published in Blood Weekly, April 8th, 1996
Blood donor screening for p24 antigen is expected to reduce by about 25 percent annually the number of HIV infected donations that otherwise would have gone undetected. In August 1995 the U.S. Food and Drug Administration (FDA) recommended that all donated blood and plasma be screened for HIV-1 p24 antigen, effective within three months of a licensed test.
The U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, has published the Public Health Service (PHS) guidelines for p24 antigen testing and donor counseling ("U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.